Literature DB >> 19584534

Characteristics of novel insect defensin-based membrane-disrupting trypanocidal peptides.

Mat Yamage1, Mikio Yoshiyama, Dennis J Grab, Masanori Kubo, Takashi Iwasaki, Hiroshi Kitani, Jun Ishibashi, Minoru Yamakawa.   

Abstract

Synthetic D- and L-amino acid type cationic 9-mer peptides (all sequences were synthesized as D- or L-amino acids) derived from the active sites of insect defensins were tested for their ability to modify the growth of blood-stream form African trypanosomes in vitro. One of them, the D-type peptide A (RLYLRIGRR-NH(2)), irreversibly suppressed proliferation of the Trypanosoma brucei brucei GUTat3.1 parasite. The presence of negatively charged phosphatidylserine on the surface of the parasites was demonstrated, suggesting electrostatic interaction between the peptide and the phospholipids. Furthermore, this peptide was found to alter trypanosome membrane-potentials significantly, an effect apparently due to the removal of the parasite's plasma membrane. The potential toxic effects of D-peptide A on mammalian cells was assessed using human brain microvascular endothelial cells. Only minor effects were found when the endothelial cells were exposed for 16 h to peptide concentrations of less than 200 microM. These findings suggest that insect defensin-based peptides represent a potentially new class of membrane-disrupting trypanocidal drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584534     DOI: 10.1271/bbb.90004

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

Review 1.  Antimicrobial peptide killing of African trypanosomes.

Authors:  J M Harrington
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

2.  A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.

Authors:  Zhengyang Zeng; Qian Zhang; Wei Hong; Yingqiu Xie; Yun Liu; Wenxin Li; Yingliang Wu; Zhijian Cao
Journal:  Toxins (Basel)       Date:  2016-04-27       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.